Chemotherapy News and Research

Latest Chemotherapy News and Research

First phase I trial of intravenous mistletoe extract to treat advanced cancer

Mistletoe extract has been widely used to support cancer therapy and improve quality of life, but there has been a lack of clinical trials and data to support its use.

22 Feb 2023

Whole genome sequencin provides clearest picture of the genetic changes leading to Hodgkin lymphoma

To create the most effective, personalized treatment plans for patients with Hodgkin lymphoma or other cancers, scientists and clinicians need the clearest picture of the genetic changes leading to the cancer's development.

21 Feb 2023

Income level impacts tumor recurrence and survival in women with ER-positive breast cancer

Patients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to have more-aggressive tumors and significantly lower overall survival (OS) than those in higher-income neighborhoods, according to research led by Roswell Park Comprehensive Cancer Center.

21 Feb 2023

Private hospitals massively underused in many areas of the UK during the pandemic

Private hospitals were paid around £2bn to help the NHS during the first year of the covid pandemic. But an investigation by The BMJ has found that just 30 of the 200 private hospitals were used to treat patients with covid-19 in April 2020 when the first pandemic wave hit its peak.

17 Feb 2023

Proposal to scrap England’s long term plan for cancer could cost lives, experts warn

The UK government's proposal to roll England's long term plan for cancer into one strategy covering all major conditions, such as cardiovascular disease, chronic respiratory disease, dementia, mental health conditions, and musculoskeletal disorders is "a catastrophic decision that will cost lives," warn experts in The BMJ today.

17 Feb 2023

The prevalence of spike-protein antibodies following at least 3 COVID-19 vaccine doses in immunocompromised individuals

Researchers determined the prevalence of antibodies against the SARS-CoV-2 spike glycoprotein following three or more doses of COVID-19 vaccines among immunocompromised individuals.

17 Feb 2023

Study provides insight into the immune microenvironment around Hodgkin lymphoma tumors

The most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumour cells must do to survive. Researchers from the Wellcome Sanger Institute found that cancer cells use signals to attract certain types of immune cell and instruct them not to attack.

16 Feb 2023

Machine learning algorithm predicts DNA insertion efficiency of prime editing

A new tool to predict the chances of successfully inserting a gene-edited sequence of DNA into the genome of a cell, using a technique known as prime editing, has been developed by researchers at the Wellcome Sanger Institute.

15 Feb 2023

Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients

Patients with resectable non-small cell lung cancer (NSCLC) who were treated with neoadjuvant nivolumab had improved five-year recurrence-free and overall survival rates compared with historical outcomes.

15 Feb 2023

Increasing numbers of cancer survivors at high risk for cardiovascular disease

American Cancer Society (ACS) research estimates there are more than 18 million adult survivors of cancer in the United States, and that number is expected to climb to more than 22 million by 2030.

15 Feb 2023

Novel predictive index for gastric cancer prognosis

A new research paper was published in Oncotarget's Volume 14 on January 31, 2023, entitled, "Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer."

15 Feb 2023

Your money or your life: Patient on $50,000-a-week cancer drug fears leaving behind huge medical debt

After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the bills.

14 Feb 2023

Over 50% of cancer patients report long COVID symptoms after recovering from COVID-19

Tesearchers investigate the persistent symptoms experienced by cancer patients who previously recovered from COVID-19.

13 Feb 2023

Scientists illuminate the mechanisms that prevent p53 activation from triggering cancer cell death

Cancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors and oncogenes.

13 Feb 2023

AI can predict the effectiveness of neoadjuvant chemotherapy in breast cancer patients

Engineers at the University of Waterloo have developed artificial intelligence (AI) technology to predict if women with breast cancer would benefit from chemotherapy prior to surgery.

7 Feb 2023

Integrated NGS system can deliver accurate, genomics-based diagnoses to accelerate treatment for myeloid neoplasms

Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients. However, treatment initiation can be delayed by the variable and lengthy turnaround times involved in testing for these alterations.

7 Feb 2023

What is the effectiveness of different exercise modalities in reducing cancer-related fatigue in cancer patients undergoing chemotherapy?

Researchers examined the effect of exercise modalities on cancer-related fatigue.

6 Feb 2023

Pembrolizumab in combination with chemotherapy improves progression free survival for women with advanced or recurrent endometrial cancer

NRG Oncology Phase III clinical trial, NRG-GY018, evaluating pembrolizumab in combination with standard of care chemotherapy (carboplatin and paclitaxel) met its primary endpoint of progression free survival (PFS) for the treatment of patients with stage III-IV or recurrent endometrial carcinoma, regardless of mismatch repair status.

3 Feb 2023

World Cancer Day 2023: Perspectives from The Institute of Cancer Therapeutics

To commemorate World Cancer Day, we spoke to a multidisciplinary team of researchers from The Institute of Cancer Therapeutics (ICT) based at the University of Bradford about their work in cancer research.

3 Feb 2023

What are the predictors of in-hospital mortality in cancer patients with COVID-19?

A new study in PLoS ONE aimed to analyze the variables associated with in-hospital mortality in COVID-19-positive cancer patients who were presented to the ED.

3 Feb 2023

Chemotherapy News and Research

Latest Chemotherapy News and Research

First phase I trial of intravenous mistletoe extract to treat advanced cancer

Whole genome sequencin provides clearest picture of the genetic changes leading to Hodgkin lymphoma

Income level impacts tumor recurrence and survival in women with ER-positive breast cancer

Private hospitals massively underused in many areas of the UK during the pandemic

Proposal to scrap England’s long term plan for cancer could cost lives, experts warn

The prevalence of spike-protein antibodies following at least 3 COVID-19 vaccine doses in immunocompromised individuals

Study provides insight into the immune microenvironment around Hodgkin lymphoma tumors

Machine learning algorithm predicts DNA insertion efficiency of prime editing

Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients

Increasing numbers of cancer survivors at high risk for cardiovascular disease

Novel predictive index for gastric cancer prognosis

Your money or your life: Patient on $50,000-a-week cancer drug fears leaving behind huge medical debt

Over 50% of cancer patients report long COVID symptoms after recovering from COVID-19

Scientists illuminate the mechanisms that prevent p53 activation from triggering cancer cell death

AI can predict the effectiveness of neoadjuvant chemotherapy in breast cancer patients

Integrated NGS system can deliver accurate, genomics-based diagnoses to accelerate treatment for myeloid neoplasms

What is the effectiveness of different exercise modalities in reducing cancer-related fatigue in cancer patients undergoing chemotherapy?

Pembrolizumab in combination with chemotherapy improves progression free survival for women with advanced or recurrent endometrial cancer

World Cancer Day 2023: Perspectives from The Institute of Cancer Therapeutics

What are the predictors of in-hospital mortality in cancer patients with COVID-19?

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in